BrockingtonA, ScottGR, Trends in survival of HIV infected patients attending the Department of Genito-urinary Medicine, Royal Infirmary of Edinburgh. Scot Med J1997; 42: 114–115.
2.
AllardiceA. More people are living with AIDS, but are they living longer?Report Answer1994; 47: 1–2.
3.
PoznanskyMC, CokerR, SkinnerC. HIV positive patients first presenting with an AIDS defining illness; characteristics and survival. Br Med J1995; 311: 156–8.
4.
MillsGD, JonesPD. Relationship between CD4 Lymphocyte count and AIDS mortality 1986–91. AIDS1993;7: 1383–6.
5.
SimpsonGR, SchultzTF, WhitbyD. Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluoresence antigen. Lancet1996; 348: 1133–38.
6.
Delta Co-ordinating Committee. Delta — a randomised double blind controlled trial comparing combinations of Zidovudine and Didanosine or Zalcitabine with Zidovudine alone in HIV infected individuals. Lancet1996; 348: 282–91.
7.
CAESAR Co-ordinating Committee. Randomised trial of addition of Lamivudine or Lamivudine plus Loviride to Zidovudine containing regimens for patients with HIV-1 infection. The CAESAR trial. Lancet1997; 349: 1413–21.
